BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer.
Flanagan L, Lindner AU, de Chaumont C, Kehoe J, Fay J, Bacon O, Toomey S, Huber HJ, Hennessy BT, Kay EW, McNamara DA, Prehn JH.
Flanagan L, et al. Among authors: de chaumont c.
J Mol Med (Berl). 2015 Mar;93(3):315-26. doi: 10.1007/s00109-014-1221-7. Epub 2014 Nov 13.
J Mol Med (Berl). 2015.
PMID: 25388617